Relationship between plasma high-mobility group box-1 levels and clinical outcomes of ischemic stroke

Journal of Critical Care

Volumn 28, Issue 5, 2013, Pages 792-797

  Huang, Ju Ming ^a   Hu, Jin ^a   Chen, Ning ^a   Hu, Min Lei ^a  

^a The First Hospital of Jia Xing   (China)

Author keywords

High mobility group box 1; Ischemic stroke; Outcome

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HIGH MOBILITY GROUP B1 PROTEIN; TICLOPIDINE; WARFARIN;

AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RANKIN SCALE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

HIGH MOBILITY GROUP BOX-1; ISCHEMIC STROKE; OUTCOME;

AGED; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HMGB1 PROTEIN; HUMANS; INFLAMMATION MEDIATORS; MAGNETIC RESONANCE IMAGING; MALE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TREATMENT OUTCOME;

EID: 84883555885     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.10.003     Document Type: Article

References (32)

1. Haraldsen G., Balogh J., Pollheimer J., et al. Interleukin-33-cytokine of dual function or novel alarmin?. Trends Immunol 2009, 30:227-233.
2. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
3. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (hmgb1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005, 5:331-342.
4. Bianchi M.E., Manfredi A.A. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 2007, 220:35-46.
5. Dumitriu I.E., Baruah P., Manfredi A.A., et al. HMGB1: guiding immunity from within. Trends Immunol 2005, 26:381-387.
6. Klune J.R., Dhupar R., Cardinal J., et al. HMGB1: endogenous danger signaling. Mol Med 2008, 14:476-484.
7. Qiu J., Nishimura M., Wang Y., et al. Early release of hmgb-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 2008, 28:927-938.
8. Kim J.B., Sig Choi J., Yu Y.M., et al. Hmgb1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 2006, 26:6413-6421.
9. Liu K., Mori S., Takahashi H.K., et al. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J 2007, 21:3904-3916.
10. Tang D., Kang R., Cao L., et al. A pilot study to detect high mobility group box 1 and heat shock protein 72 in cerebrospinal fluid of pediatric patients with meningitis. Crit Care Med 2008, 36:291-295.
11. Goldstein R.S., Gallowitsch-Puerta M., Yang L., et al. Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock 2006, 25:571-574.
12. Vogelgesang A., May V.E., Grunwald U., et al. Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS One 2010, 5(1):e8718.
13. King M.D., Laird M.D., Ramesh S.S., et al. Elucidating novel mechanisms of brain injury following subarachnoid hemorrhage: an emerging role for neuroproteomics. Neurosurg Focus 2010, 28:E10.
14. Nakahara T., Tsuruta R., Kaneko T., et al. High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage. Neurocrit Care 2009, 11:362-368.
15. Zhou Y., Xiong K.L., Lin S., et al. Elevation of high-mobility group protein box-1 in serum correlates with severity of acute intracerebral hemorrhage. Mediators Inflamm 2010, pii: 142458.
16. Landsman D., Bustin M.A. Signature for the HMG-1 box DNA binding proteins. Bioessays 1993, 15:539-546.
17. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999, 19:5237-5246.
18. Abraham E., Arcaroli J., Carmody A., et al. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165:2950-2954.
19. Wang H., Bloom O., Zhang M., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
20. Bonaldi T., Talamo F., Scaffidi P., et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003, 22:5551-5560.
21. Agnello D., Wang H., Yang H., et al. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 2002, 18:231-236.
22. Kim J.B., Lim C.M., Yu Y.M., et al. Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain. J Neurosci Res 2008, 86:1125-1131.
23. Muhammad S., Barakat W., Stoyanov S., et al. The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci 2008, 28:12023-12031.
24. Wang H., Vishnubhakat J.M., Bloom O., et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999, 126:389-392.
25. O'Connor K.A., Hansen M.K. Rachal Pugh C, et al. Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects. Cytokine 2003, 24:254-265.
26. Huttunen H.J., Fages C., Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999, 274:19919-19924.
27. Park J.S., Arcaroli J., Yum H.K., et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003, 284:C870-C879.
28. Taguchi A., Blood D.C., del Toro G., et al. Blockade of RAGE amphoterin signalling suppresses tumour growth and metastases. Nature 2000, 405:354-360.
29. Huttunen H.J., Rauvala H. Amphoterin as an extracellular regulator of cell motility: from discovery to disease. J Int Med 2004, 255:351-366.
30. Park J.S., Svetkauskaite D., He Q., et al. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004, 279:7370-7377.
31. Schmidt A.M., Yan S.D., Yan S.F., et al. The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 2000, 1498:99-111.
32. Tsung A., Sahai R., Tanaka H., et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005, 201:1135-1143.